Invitro antimicrobial efficiency of Lawsonia inermis L (Henna) extracts against Multidrug Resistant Microorganisms

Abstract Antibiotics are becoming less effective as drug resistance spreads throughout the world, making it ever more difficult to treat the disease. The effect of biotic stress on antimicrobial activity of Lawsonia inermis L. (Henna) was studied as an alternate to antimicrobial agents against multidrug resistant microorganisms. The study was carried out in Molecular Biochemistry Lab, Department of Biochemistry, University of Agriculture Faisalabad. The plant seedlings were given biotic stress with Fusarium solani. The induced extracts were harvested at different time intervals and the antimicrobial activity was investigated by disc diffusion method. The induced plant extracts revealed highest susceptibility against S. aureus (30±0.02) and Pasteurella multocida (30±0.01) at 12 hpi. The least activity was shown against all the strains at 0 hpi. The highest antifungal activity was found against Ganoderma lucidum (55±0.05) at 24 hpi. The results demonstrated a significant difference in the antimicrobial activities of all the strains with and without fungal stress (P<0.05). The fungal induced extracts of Lawsonia inermis L (Henna) with enhanced antimicrobial activity may have the potential of being alternative and cost- effective agents against antimicrobial resistance

Overview of Liquid Crystal Research: Computational Advancements, Challenges, Future Prospects and Applications

Liquid crystal (LC) is a fascinating state of matter that combines order and mobility at multiple hierarchical levels, spanning from nanoscale to the macroscale, or from molecular to the macroscopic, and is composed of molecules and layers as thin as of a few nanometer in size. This unique combination allows such a system to adapt to a wide range of external stimuli, including temperature, magnetic field, electric field, mechanical stress, light, chemical reaction, and electrochemical response, by determining a new lowest energy configuration. Liquid crystalline nanostructures efficiently transmit and amplify information and attributes over macroscopic sizes due to their dynamic nature. The responsiveness and diversity of LCs provide enormous potential and challenges for fundamental scientific insights as well as opening the door to countless applied applications. Recent breakthroughs in nanotechnology have boosted the discipline, both in terms of theoretical simulations and the ability to fabricate nanoscale structures such as sub-wavelength gratings, nanoporous materials, and nanoparticles. Because LC materials are switchable, a new family of active plasmonic and nanophotonic devices is emerging, describing fascinating basic research processes as well as the creation of upgraded devices. This chapter discusses the fundamentals, computational advances, future prospects and challenges, as well as potential applications of LCs

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

The Study of the Structural, Morphological, and Mechanical Characteristics of the Laser-Irradiated Aluminium Targets

Aluminium samples are irradiated using a continuous-wave diode laser in a laboratory environment to study the effect on its surface, structural, and mechanical properties. The exposed samples are investigated by scanning electron microscopy and x-ray diffractometer for the surface and structural morphology, respectively. The scanning electron microscopic analysis unveils the realization of micrometer grain size, exfoliational sputtering, and crater production. The diffractometric x-ray analysis reveals the grain size, d-spacing, and dislocation line density of the targeted samples. The hardness of the samples as a function of exposure time is investigated using the micro Vickers hardness tester to perceive the mechanical properties. An increase in micro-hardness is observed with the increase in the exposure time

Ex Situ Synthesis and Characterizations of MoS₂/WO₃ Heterostructures for Efficient Photocatalytic Degradation of RhB

In this study, novel hydrothermal ex situ synthesis was adopted to synthesize MoS2/WO3 heterostructures using two different molar ratios of 1:1 and 1:4. The “bottom-up” assembly was successfully developed to synthesize spherical and flaky-shaped heterostructures. Their structural, morphological, compositional, and bandgap characterizations were investigated through XRD, EDX, SEM, UV-Visible spectroscopy, and FTIR analysis. These analyses help to understand the agglomerated heterostructures of MoS2/WO3 for their possible photocatalytic application. Therefore, prepared heterostructures were tested for RhB photodegradation using solar light irradiation. The % efficiency of MoS2/WO3 composites for 30 min irradiation of 1:1 was 91.41% and for 1:4 was 98.16%. Similarly, the % efficiency of 1:1 MoS2/WO3 heterostructures for 60 min exposure was 92.68%; for 1:4, it was observed as 98.56%; and for 90 min exposure, the % efficiency of 1:1 was 92.41%, and 98.48% was calculated for 1:4 composites. The photocatalytic efficiency was further verified by reusability experiments (three cycles), and the characterization results afterward indicated the ensemble of crystalline planes that were responsible for the high efficiency. Moreover, these heterostructures showed stability over three cycles, indicating their future applications for other photocatalytic applications

Appraisal of wild fig fruits for nutra-pharmaceutical and biological attributes

The fruits of wild fig, native to Soon valley of Pakistan, were appraised for phenolic compounds and high-value nutrients. These fruits were shade-dried and extracted with different solvents of varying polarity to recover a wide range of antioxidant components, where hydroxyethanol exhibited highest extraction yield of antioxidant compounds. Among others, hydroxyethanol-derived crude concentration extracts (CCEs) and phenolic rich fractions (PRFs) showed greater amount of total phenolic, flavonoids and superior biological properties. The fruits of tested fruits were found to possess potassium (11.34 g/kg) and calcium (4.19 g/kg) as major elements, glucose (5.63g/100g DW) as dominant natural sugar and acetic acid (2.40 mg/100 g of dry matter) as principal organic acid. There was a considerable (p < 0.05) variation in phenolic content and biological properties of various extracts recovered with different solvents. Furthermore, the biological properties of tested fruits were found to be significantly correlated with their intrinsic total phenolic content (TPC) and total flavonoid content (TFC). Based upon the findings of present study, the fruits of wild fig could be treated as promising source of beneficial nutrients and potent phenolic components for their applications in the development of nutrapharmaceuticals

Advancing photocatalysis: Innovative approaches using novel V2O5/ZnO nanocomposites for efficient photocatalytic degradation of tubantin red

Photocatalytic response of V2O5, ZnO, and V2O5/ZnO nanostructures for the degradation of Tubantin red 8BL dye has been reported. Pure V2O5, ZnO, and V2O5/ZnO composite nanostructures were synthesized through a hydrothermal method. UV–Visible spectroscopy, scanning electron microscopy (SEM), energy dispersive X-ray microscopy (EDX), and Fourier-transform infrared spectroscopy (FTIR) characterizations were done to examine their bandgap energy (Eg), morphology, composition, and structure, respectively. These discoveries advance our knowledge of the agglomerated nanoparticles of V2O5, ZnO, and V2O5/ZnO for their prospective photocatalytic uses. The presence of V2O5 and ZnO in composite is confirmed through the analysis of FTIR. Flower shaped morphology was observed in V2O5/ZnO nanocomposite by SEM. The 2.83 eV bandgap energy was observed in composite. The nanocomposite was evaluated for Tubantin red 8BL photodegradation. The efficiencies of pure ZnO nanoparticles after 25 min, 50 min, 75 min, 100 min, 125 min, and 150 min irradiation are 54.54 %, 58.00 %, 61.41 %, 63.84 %, 71.19 %, and 78.53 %; for pure V2O5 nanoparticles, they are 72.72 %, 76.45 %, 80.85 %, 85.42 %, 89.99 %, and 94.32 %. Similarly, the efficiencies (%) of V2O5/ZnO composite nanoparticles are 45.10 %, 53.27 %, 60.75 %, 68.24 %, 79.99 %, 91.74 %, and 99.79 %, respectively. Reusability studies (three cycles) were used to further confirm the photocatalytic efficiency, and the findings of the subsequent characterization revealed an arrangement of crystalline layers which is the cause of the high efficiency. These nanostructures also demonstrated stability across three cycles, suggesting more photocatalytic uses for them in the future

Antibiotic Drug Resistance Pattern of Uropathogens in Pediatric Patients in Pakistani Population

The common prevalent diseases in the age of 0 to 6 are related to urinary tract infections. If not properly diagnosed, they will lead to urological and nephrological complications. Uropathogens are developing resistance against most drugs and are harder to treat. A study was done on the inpatients and outpatients of the two hospitals located in Lahore. A total of 39,750 samples that were both male and female were collected. Escherichia and Klebsiella were found in 234 samples based on biochemical characterization, growth on CLED agar, and white blood cell/pus cell (WBC) microscopy. In comparison to males, female samples had a higher number of uropathogens (1:1.29). From the samples of Shaikh Zayed Hospital (SZH), the ratio of Klebsiella to Escherichia (1:1.93) was reported, while this ratio was 1.84:1 from the Children Hospital (CH). The incidence of UTI was higher in the month of September. Randomly selected Escherichia and Klebsiella were verified via a 16S rRNA sequence. Antibiotic resistance profiling of isolated bacterial strains was done against 23 antibiotics. The most efficient antibiotics against Klebsiella and Escherichia were colistin sulphate (100% sensitivity against bacteria from CH; 99.3% against strains from SZH) and polymyxin B (100% sensitivity against strains from SZH; 98.8% against strains from CH). Sensitivity of the total tested strains against meropenem (74%, SZH; 70% CH), Fosfomycin (68%, SZH; 73% CH strains), amikacin (74% SZH; 55% CH), and nitrofurantoin (71% SZH;67% CH) was found, Amoxicillin, ampicillin, and cefuroxime showed 100 to ≥90% resistance and are the least effective